论文部分内容阅读
自广泛应用乙型肝炎表面抗原(HBsAg)检测乙型肝炎以来,世界各地普遍发现原发性肝细胞癌(PHC)的HBsAg检出率明显地高于健康人群。近年来又证明血清中乙型肝炎核心抗体(抗-HBc)是乙型肝炎病毒(HBV)感染的一个指标,它是HBV在体内复制的反映。我们对部份确诊为PHC的病例进行了HBV感染情况的检测,现作简要介绍。 一、方法及结果 1.观察对象:24例PHC病人均经临床检查及血清胎甲蛋白血凝试验确诊,计男21,女3,年龄22～28岁。对每例患者均取静脉血作有关乙型肝炎血清学检测。另外选当地某公社一般人群中胎甲蛋白血凝
Since the widespread use of Hepatitis B surface antigen (HBsAg) to detect hepatitis B, the prevalence of HBsAg in primary hepatocellular carcinoma (PHC) worldwide has been significantly higher than that of healthy individuals. In recent years it has also been demonstrated that serum hepatitis B core antibody (anti-HBc) is an indicator of hepatitis B virus (HBV) infection and is a reflection of HBV replication in vivo. We conducted a survey of HBV infection in some of our patients who were diagnosed with PHC. First, the method and results 1.Objective: 24 cases of PHC patients were clinically diagnosed and serum fetal nail protein hemagglutination test confirmed, accounting for male 21, female 3, aged 22 to 28 years. For each patient were taken venous blood for hepatitis B serology. In addition, the general election of a local commune in fetal protein hemagglutination